rs34299874
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_003042.4(SLC6A1):c.535A>G(p.Met179Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00154 in 1,613,454 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M179L) has been classified as Likely benign.
Frequency
Consequence
NM_003042.4 missense
Scores
Clinical Significance
Conservation
Publications
- epilepsy with myoclonic atonic seizuresInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Illumina, G2P, Labcorp Genetics (formerly Invitae)
- myoclonic-astatic epilepsyInheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC6A1 | NM_003042.4 | c.535A>G | p.Met179Val | missense_variant | Exon 6 of 16 | ENST00000287766.10 | NP_003033.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00832 AC: 1266AN: 152204Hom.: 21 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00215 AC: 537AN: 250100 AF XY: 0.00158 show subpopulations
GnomAD4 exome AF: 0.000828 AC: 1210AN: 1461132Hom.: 13 Cov.: 30 AF XY: 0.000711 AC XY: 517AN XY: 726754 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00833 AC: 1269AN: 152322Hom.: 21 Cov.: 33 AF XY: 0.00854 AC XY: 636AN XY: 74488 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3
- -
- -
- -
Epilepsy with myoclonic atonic seizures Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at